RCA
ABBV icon

Ranch Capital Advisors’s AbbVie ABBV Stock Holding History

Ranch Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.05M Buy
16,101
+1,213
+8% +$261K 1.28% 24
2026
Q1 		$3.24M Buy
14,888
+4,017
+37% +$891K 1.17% 29
2025
Q4 		$2.48M Buy
10,871
+322
+3% +$73.4K 0.91% 34
2025
Q3 		$2.44M Buy
10,549
+409
+4% +$83.3K 0.95% 36
2025
Q2 		$1.88M Buy
10,140
+168
+2% +$31.2K 0.82% 41
2025
Q1 		$2.09M Buy
9,972
+379
+4% +$73.7K 0.99% 35
2024
Q4 		$1.7M Sell
9,593
-3,056
-24% -$562K 0.81% 43
2024
Q3 		$2.5M Buy
12,649
+931
+8% +$174K 1.18% 25
2024
Q2 		$2.01M Buy
11,718
+243
+2% +$40.3K 1.05% 26
2024
Q1 		$2.09M Buy
11,475
+145
+1% +$25K 1.13% 24
2023
Q4 		$1.76M Buy
11,330
+6,996
+161% +$1.02M 1.09% 25
2023
Q3 		$646K Hold
4,334
– – 0.45% 69
2023
Q2 		$584K Sell
4,334
-57
-1% -$8.36K 0.41% 77
2023
Q1 		$700K Sell
4,391
-133
-3% -$20.3K 0.51% 62
2022
Q4 		$731K Hold
4,524
– – 0.57% 58
2022
Q3 		$607K Buy
4,524
+2
+0% +$287 0.5% 68
2022
Q2 		$693K Sell
4,522
-73
-2% -$11.2K 0.53% 65
2022
Q1 		$745K Buy
4,595
+2
+0% +$291 0.49% 68
2021
Q4 		$622K Buy
4,593
+824
+22% +$97.3K 0.4% 83
2021
Q3 		$407K Buy
3,769
+103
+3% +$11.8K 0.25% 103
2021
Q2 		$412K Sell
3,666
-80
-2% -$9.01K 0.25% 108
2021
Q1 		$405K Buy
3,746
+12
+0.3% +$1.28K 0.27% 101
2020
Q4 		$400K Buy
3,734
+269
+8% +$25.9K 0.29% 95
2020
Q3 		$303K Buy
3,465
+163
+5% +$15.3K 0.24% 101
2020
Q2 		$305K Buy
3,302
+61
+2% +$5.37K 0.24% 105
2020
Q1 		$246K Sell
3,241
-117
-3% -$9.97K 0.24% 106
2019
Q4 		$297K Sell
3,358
-131
-4% -$10.9K 0.24% 116
2019
Q3 		$264K Buy
+3,489
New +$239K 0.28% 110

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ranch Capital Advisors's ABBV Position: Q2 2026 in Review

Ranch Capital Advisors increased its AbbVie (ABBV) stake by 8.1% in Q2 2026, buying an estimated $261K and bringing the position to 16,101 shares worth $4.05M. The position accounts for 1.28% of the portfolio, ranked #24.

Ranch Capital Advisors first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ranch Capital Advisors held 16,101 shares of AbbVie worth $4.05M as of Q2 2026.
  • Ranch Capital Advisors bought 1,213 AbbVie shares in Q2 2026, an estimated $261K.
  • AbbVie made up 1.28% of Ranch Capital Advisors's portfolio in Q2 2026, its #24 holding.
  • Ranch Capital Advisors first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ranch Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.